EDUCATION

– Washington University in St. Louis, B.A. Biology, 2006 – University of Louisville, School of Dentistry, DMD, 2011 – Implant Preceptorship, University of Texas, School of Dentistry, San Antonio, 2014 – Level III Moderate Conscious Parenteral (IV) Sedation, Texas State Board of Dental Examiners – Licensed in California, Texas, Kentucky.

WORK EXPERIENCE AND INTERESTS

Dr. Christopher Doane has been a dentist in Texas for eight years and enjoys helping people. Dr. Doane has completed the Preceptorship in Dental Implantology at the University of Texas, Health Science Center San Antonio, School of Dentistry. Also, Dr. Doane is IV Sedation certified by the Texas State Board of Dental Examiners. He has seen patients in many office environments from small privately owned to large corporate group practices, and has learned a lot from that variety. Dr. Doane made a potentially important discovery in the field of infectious disease while an undergraduate at Washington University in St. Louis. While performing research as a Howard Hughes Medical Institute Undergraduate Fellow, Dr. Doane played a key role in developing a patented drug being tested as a cure for West Nile Virus infection. The FDA testing process has gone through phase I and II.

ACHIEVEMENTS

– Howard Hughes Medical Institute Undergraduate Fellow, Washington University in St. Louis, School of Medicine, Infectious Disease Department, 2002
– Author, Nature Medicine, “Development of a Humanized Monoclonal Antibody with Therapeutic Potential Against West Nile Virus,” 2005
– Patent Holder, US Patents # 7527973 and # 7981422 accepted in 2009. Co-Inventor of the antibody that may be first therapeutic for West Nile Virus infection. Dr. Doane performed the research at Washington University in St. Louis, School of Medicine.